TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 4 | 3 | 5 | 25 | 31 | 21 | 78 | 27 |
| P | %wins | 75 | 75 | 75 | 50 | 50 | 100 | 71 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/2/15 11:40 | 10/29/15 | GNMK | Genmark Diagnostics, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Faulkner Daryl | CA | D | P | 29 | 7.33 | 4 | 4 | 8 | 53 | D | -48 | -38 | -38 | -21 | -37 | -29 | -19 | -6 | 5 | 13 | 21 | -19 | -10 | 68 | |
6/28/12 18:18 | 6/26/12 | GNMK | Genmark Diagnostics, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Faulkner Daryl | CA | D | P | 21 | 4.20 | 1 | 5 | 19 | 32 | D | 1 | -27 | -1 | 4 | -9 | -2 | -4 | 0 | 3 | 11 | 34 | 114 | 106 | 148 | |
6/7/10 17:35 | 6/3/10 | GNMK | Genmark Diagnostics, Inc. | DE | Health | MdEq | Surgical & Medical Instrument | Faulkner Daryl | CA | D | P.d | 100 | 6.00 | 1 | 17 | New | 17 | D | -1 | 5 | 0 | -2 | -18 | -17 | 8 | ||||||||
5/21/09 13:16 | 5/19/09 | APPY | Aspenbio Pharma, Inc. | CO | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkner Daryl | CO | DO | CEO,Exec | P.d | 16 | 1.55 | 0 | 10 | New | 10 | I | -63 | -70 | -69 | 14 | -12 | -6 | -8 | 1 | -1 | -3 | 48 | 46 | 3 | 89 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |